ClinConnect ClinConnect Logo
Search / Trial NCT01130974

A Study to Assess the Safety and Efficacy of a Daily Disposable Contact Lens

Launched by BAUSCH & LOMB INCORPORATED · May 25, 2010

Trial Information

Current as of August 02, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Subjects must have clear central corneas and be free of any anterior segment disorders.
  • Subjects must be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
  • Subjects must be correctable through spherocylindrical refraction to 32 letters (0.3 logMAR) or better (distance, high contrast) in each eye.
  • Subjects must be of Asian descent.
  • Subjects must require plano or myopic correction and must require contact lens correction from plano to -6.00 D in both eyes.
  • Exclusion Criteria:
  • Subjects who have any systemic disease affecting ocular health.
  • Subjects using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
  • Subjects with an active ocular disease or are using any ocular medication.
  • Subjects with any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
  • Subjects with any scar or neovascularization within the central 4 mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area), that in the Investigator's judgment, does not interfere with contact lens wear, are eligible for this study.
  • Subjects who currently wear monovision, multifocal, or toric contact lenses.
  • Subjects who are adapted wearers of 1-Day Acuvue Define daily disposable cosmetic tint contact lenses.

About Bausch & Lomb Incorporated

Bausch & Lomb Incorporated is a leading global eye health company dedicated to advancing the vision and well-being of individuals through innovative products and solutions. With a rich history spanning over 160 years, Bausch & Lomb specializes in the development, manufacturing, and marketing of a comprehensive range of eye care products, including contact lenses, lens care solutions, and pharmaceuticals for various ocular conditions. The company is committed to rigorous clinical research and trials to ensure the safety and efficacy of its offerings, striving to enhance patient outcomes and improve quality of life for those with vision-related challenges.

Locations

Rochester, New York, United States

Patients applied

0 patients applied

Trial Officials

Bev Barna

Study Director

Bausch & Lomb Incorporated

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials